Navigation Links
TGen President Dr. Jeffrey Trent speaks at Brookings Institution biomedical conference
Date:7/15/2013

WASHINGTON, D.C. July 15, 2013 Dr. Jeffrey Trent, President and Research Director for the Translational Genomics Research Institute (TGen), will discuss state-of-the-art genomics research July 16 at the Brookings Institution.

Dr. Trent, Ph.D., F.A.C.M.G., and former Scientific Director of the National Human Genome Research Institute, is part of a panel, Innovation in Action, at Brookings' 2nd annual State of Biomedical Innovation Conference, which will focus on the use of novel data sources to improve medical product development and care delivery.

Specifically, Dr. Trent will discuss TGen's ongoing work in translating genomics research into clinical benefit. TGen is one of a very few centers who are using the entire human genome in clinical trials in order to diagnose or make treatment decisions for an individual patient (precision medicine).

"The human genome will be the medical textbook for the next century and beyond," Dr. Trent said. "By harnessing the power of the human genome, we will provide immeasurable patient benefit while at the same time reducing the time and costs of diagnosis and treatment. TGen is a global leader in clinical trials that deploy this form of innovative research."

TGen's translational model enables pioneering discoveries in the laboratory to be quickly moved to clinical trials where they can be used to immediately benefit patients with many types of cancer and other debilitating diseases.

Dr. Trent's panel will be moderated by Dr. Mark B. McClellan, Director and Fellow of Brookings' Initiative on Innovation and Value in Health Care. He is the former administrator for the Centers for Medicare and Medicaid Services (2004-2006), and the former commissioner of the Food and Drug Administration (2002-2004). He also served as a member of the President's Council of Economic Advisers, and as senior director for health care policy at the White House (2001-2002). In these positions, he developed and implemented major reforms in health policy.

This conference is being convened by the Engelberg Center for Health Care Reform at Brookings, which was established to help turn ideas for health care reform into action, including reducing gaps in insurance coverage and ensuring health care affordability. Its mission is to develop data-driven, practical policy solutions that promote broad access to high-quality, affordable and innovative care in the United States. The Center also conducts research, makes policy recommendations, and facilitates development of new consensus around key issues, providing technical support to implement and evaluate new solutions in collaboration with a broad range of stakeholders.

The conference is scheduled for 9 a.m.-12:30 p.m. EDT July 16 at the Brookings Institution, Falk Auditorium, 1775 Massachusetts Avenue, N.W., Washington, D.C. Dr. Trent's hour-long panel is scheduled to start at 10:10 a.m. The event will be streamed live on the Brookings website: http://www.brookings.edu/events/2013/07/16-biomedical-innovation.


'/>"/>

Contact: Steve Yozwiak
syozwiak@tgen.org
602-343-8704
The Translational Genomics Research Institute
Source:Eurekalert

Related biology news :

1. BioNano Genomics Appoints Dr. Fahim Amini As Vice President Commercial Operations EMEA
2. Homeland Security Corporation (HSCC) Appoints New President with Biometrics and Access Control Solutions Expertise and Contacts
3. Statement by WCS president and CEO on historic CITES ruling
4. FASEB joins President Obama in urging Congress to sustain investments in research and innovation
5. Bluemetal Architects appoints David Le Penske as Vice President of Health & Life Sciences
6. President Obama honors MU researcher with National Medal of Science
7. ONR-funded young innovators recognized by President
8. NASA Goddard scientist receives Presidential Early Career Award
9. 3-V Biosciences Appoints Douglas I. Buckley, PhD, as Vice President of Biology
10. UCLAs Yi Tang receives Presidential Green Chemistry Challenge Award from EPA
11. President, CEO Leppävuori, VTT: Finland should create a national bioeconomy strategy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2019)... ... June 24, 2019 , ... According to the World Health Organization , ... common STDs: chlamydia, gonorrhea, trichomoniasis (or "trich") and syphilis. And that’s not counting HIV. ... American men accounted for the largest number of HIV diagnoses (9,807), followed by Hispanic/Latino ...
(Date:6/16/2019)... TX (PRWEB) , ... June 14, 2019 , ... ... three Americans invited to lecture at the fifth annual Neodent World Congress. Attended ... explored the innovative progress and latest advancements in the world of dentistry. The ...
(Date:6/13/2019)... , ... June 13, 2019 , ... ... the first organization exclusively serving the end-to-end clinical and ancillary supply chain management ... as contract and medical research organizations, today announced it will sponsor a summer ...
Breaking Biology News(10 mins):
(Date:5/21/2019)... ADDIS ABABA, Ethiopia (PRWEB) , ... May 21, ... ... Lehranstalt für Brauerei in Berlin (VLB) today officially opened the inaugural Africa Brewing ... the brewing and malting industry in Africa. The event, which is supported through ...
(Date:5/15/2019)... ... May 16, 2019 , ... ... As a result, food and beverage products rely on these ingredients to create ... natural sounding label declarations. This paradigm shift triggers food formulators to seek out ...
(Date:5/14/2019)... Calif. (PRWEB) , ... May 14, 2019 , ... ... office expansion, effectively doubling its space from 2,500 to 5,000 square feet. , ... Early Gender DNA tests ,” says Gateway Genomics CEO, Chris Jacob. “The SneakPeek At-Home ...
(Date:5/7/2019)... ... May 06, 2019 , ... "The new Liquid Nitrogen ... repositories being asked to store cellular products being used in adoptive therapy ... are world leaders, who have shared their expertise in building and managing facilities ...
Breaking Biology Technology: